
Global Cord Blood Corporation CO
Annual report 2022
added 08-16-2022
Global Cord Blood Corporation Operating Cycle 2011-2026 | CO
Annual Operating Cycle Global Cord Blood Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 202 | 186 | 138 | 94 | 101 | 136 | 144 | 139 | 180 | 87.4 | 104 | 116 |
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 202 | 87.4 | 136 |
Quarterly Operating Cycle Global Cord Blood Corporation
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 54.4 | - | - | - | 76.7 | - | - | - | 40 | - | - | - | 50.7 | - | - | - | 60.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 96.3 | 180 | - | - | 74.5 | 187 | 220 | 120 | 60.4 | 55.8 | - |
All numbers in CNY currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 220 | 40 | 98.1 |
Operating Cycle of other stocks in the Diagnostics research industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Castle Biosciences
CSTL
|
97.4 | $ 19.24 | -22.26 % | $ 558 M | ||
|
Centogene N.V.
CNTG
|
170 | - | -6.23 % | $ 30.6 M | ||
|
Burning Rock Biotech Limited
BNR
|
275 | $ 16.58 | -2.53 % | $ 175 M | ||
|
Agilent Technologies
A
|
161 | $ 118.65 | 0.82 % | $ 36.1 B | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
1.2 K | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
489 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 21.44 | 2.39 % | $ 1.14 B | ||
|
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | ||
|
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 428.71 | 0.45 % | $ 12.4 B | ||
|
Co-Diagnostics
CODX
|
1.79 K | $ 1.93 | 17.68 % | $ 2.57 M | ||
|
Myriad Genetics
MYGN
|
95.1 | $ 4.09 | -0.49 % | $ 379 M | ||
|
NeoGenomics
NEO
|
102 | $ 9.07 | 2.02 % | $ 1.16 B | ||
|
National Research Corporation
NRC
|
29.4 | $ 18.73 | 4.87 % | $ 419 M | ||
|
Natera
NTRA
|
81.5 | $ 219.82 | 2.2 % | $ 21.6 B | ||
|
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
185 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | ||
|
Koninklijke Philips N.V.
PHG
|
89 | $ 27.16 | -0.26 % | $ 25.8 B | ||
|
Charles River Laboratories International
CRL
|
65 | $ 181.68 | -0.03 % | $ 9 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | ||
|
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K | ||
|
Personalis
PSNL
|
55.8 | $ 5.99 | -1.32 % | $ 355 M | ||
|
Exact Sciences Corporation
EXAS
|
91.7 | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
77.4 | $ 15.11 | 1.27 % | $ 457 M | ||
|
Guardant Health
GH
|
128 | $ 92.26 | 0.01 % | $ 11.6 B | ||
|
Soleno Therapeutics
SLNO
|
1.04 K | $ 52.95 | 0.02 % | $ 2.69 B | ||
|
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
68.5 | $ 125.0 | 0.7 % | $ 10.3 B | ||
|
Illumina
ILMN
|
198 | $ 138.71 | -2.71 % | $ 22.1 B | ||
|
Senseonics Holdings
SENS
|
104 | $ 5.36 | - | $ 224 M | ||
|
Interpace Biosciences
IDXG
|
96 | $ 2.0 | -5.22 % | $ 8.85 M | ||
|
Trinity Biotech plc
TRIB
|
299 | $ 0.59 | -1.99 % | $ 212 M | ||
|
QIAGEN N.V.
QGEN
|
172 | - | - | $ 10.6 B | ||
|
Twist Bioscience Corporation
TWST
|
96.1 | $ 58.54 | -1.66 % | $ 3.5 B | ||
|
Biomerica
BMRA
|
204 | $ 2.19 | -0.68 % | $ 5.03 M | ||
|
Thermo Fisher Scientific
TMO
|
70 | $ 474.46 | 0.32 % | $ 179 B | ||
|
Lantheus Holdings
LNTH
|
121 | $ 91.0 | 5.63 % | $ 6.14 B | ||
|
Laboratory Corporation of America Holdings
LH
|
71.8 | $ 258.05 | 0.43 % | $ 21.5 B | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
213 | $ 9.25 | 0.76 % | $ 2.01 B | ||
|
Quest Diagnostics Incorporated
DGX
|
54.2 | $ 190.84 | 0.9 % | $ 21.2 B | ||
|
Waters Corporation
WAT
|
834 | $ 350.49 | 0.27 % | $ 20.9 B |